VIAD PHARMA ApS: Financial statements 2023
CVR: 36433892
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,257,513 and a net result of DKK 376,249 compared with DKK 188,288 the year before. That is an increase of 24.9% compared with the year before. Equity in the 2023 report amounted to DKK 444,615. The solvency ratio was 15.3%.
- Gross Profit
- DKK 1,257,513
- Profit/Loss
- DKK 376,249
- Equity
- DKK 444,615
- Total Assets
- DKK 2,913,871
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.3 mio. | 376 t. | 445 t. | - |
| 2022 | - | 1 mio. | 188 t. | 257 t. | - |
| 2021 | - | 1 mio. | 250 t. | 319 t. | - |
| 2020 | - | 1.3 mio. | 458 t. | 526 t. | - |
| 2019 | - | 1.4 mio. | 555 t. | 668 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
VIAD PHARMA ApS has published its annual report for 2022. Gross profit came to DKK 1,006,597, and the net result was DKK 188,288.
About VIAD PHARMA ApS
VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity in the 2025 report amounted to DKK 236,399.